Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

February 2017 - FRMC

Department
02/15/2017
Research showed that a biosimilar version of Neulasta (pegfilgrastim) was safe and effective among patients with breast cancer receiving myelotoxic chemotherapy. 
Research showed that a biosimilar version of Neulasta (pegfilgrastim) was safe and effective among patients with breast cancer receiving myelotoxic chemotherapy. 
Research showed that a...
02/15/2017
First Report Managed Care
Department
02/15/2017
Common menopausal symptoms such as nausea and headaches can be used as predictive tools for adherence to the aromatase inhibitor tamoxifen, according to an analysis of data from the International Breast Cancer Intervention Study (IBIS-1).
Common menopausal symptoms such as nausea and headaches can be used as predictive tools for adherence to the aromatase inhibitor tamoxifen, according to an analysis of data from the International Breast Cancer Intervention Study (IBIS-1).
Common menopausal symptoms such...
02/15/2017
First Report Managed Care
Department
02/15/2017
A recent presentation at the 2016 San Antonio Breast Cancer Symposium, entitled “Value of Cancer Care for Metastatic Breast Cancer Patients and Providers,” found that goals in value-based frameworks for breast cancer patients are not...
A recent presentation at the 2016 San Antonio Breast Cancer Symposium, entitled “Value of Cancer Care for Metastatic Breast Cancer Patients and Providers,” found that goals in value-based frameworks for breast cancer patients are not...
A recent presentation at the...
02/15/2017
First Report Managed Care
Department
02/15/2017
Increasing exposure of patients to actual drug prices, through reduced insurance coverage, has made cost a necessary factor in cancer treatment value discussions, argued Peter P Bach, MD, MAPP, director of the Center for Health Policy and...
Increasing exposure of patients to actual drug prices, through reduced insurance coverage, has made cost a necessary factor in cancer treatment value discussions, argued Peter P Bach, MD, MAPP, director of the Center for Health Policy and...
Increasing exposure of patients...
02/15/2017
First Report Managed Care
Department
02/15/2017
AMCP Annual Meeting 2017 - March 27-30, 2017, Denver, CO
AMCP Annual Meeting 2017 - March 27-30, 2017, Denver, CO
AMCP Annual Meeting 2017 - March...
02/15/2017
First Report Managed Care

Advertisement

Advertisement

Advertisement